Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Change in Receivables (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Change in Receivables for 6 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables rose 14.58% year-over-year to -$1.8 million, compared with a TTM value of -$1.2 million through Dec 2025, down 119.07%, and an annual FY2025 reading of -$1.2 million, down 119.07% over the prior year.
  • Change in Receivables was -$1.8 million for Q4 2025 at Viemed Healthcare, down from -$968000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $6.0 million in Q1 2024 and bottomed at -$2.8 million in Q2 2022.
  • Average Change in Receivables over 5 years is $793700.0, with a median of $480000.0 recorded in 2021.
  • The sharpest move saw Change in Receivables surged 598.64% in 2024, then tumbled 7966.67% in 2025.
  • Year by year, Change in Receivables stood at $1.8 million in 2021, then plummeted by 77.6% to $397000.0 in 2022, then soared by 32.24% to $525000.0 in 2023, then crashed by 507.62% to -$2.1 million in 2024, then rose by 14.58% to -$1.8 million in 2025.
  • Business Quant data shows Change in Receivables for VMD at -$1.8 million in Q4 2025, -$968000.0 in Q3 2025, and -$240000.0 in Q2 2025.